These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 36134916)

  • 1. Immunomodulation, Toxicity, and Therapeutic Potential of Nanoparticles.
    Pandey A; Mishra AK
    BioTech (Basel); 2022 Sep; 11(3):. PubMed ID: 36134916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of engineered nanoparticles on the innate immune system.
    Liu Y; Hardie J; Zhang X; Rotello VM
    Semin Immunol; 2017 Dec; 34():25-32. PubMed ID: 28985993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory and immune-toxicological role of nanoparticles: Potential therapeutic applications.
    Sau S; Dey A; Pal P; Das B; Maity KK; Dash SK; Tamili DK; Das B
    Int Immunopharmacol; 2024 Jun; 135():112251. PubMed ID: 38781608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper oxide nanoparticles: In vitro and in vivo toxicity, mechanisms of action and factors influencing their toxicology.
    Sajjad H; Sajjad A; Haya RT; Khan MM; Zia M
    Comp Biochem Physiol C Toxicol Pharmacol; 2023 Sep; 271():109682. PubMed ID: 37328134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the toxicity of selected types of nanochemicals.
    Kumar V; Kumari A; Guleria P; Yadav SK
    Rev Environ Contam Toxicol; 2012; 215():39-121. PubMed ID: 22057930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review.
    Abbasi R; Shineh G; Mobaraki M; Doughty S; Tayebi L
    J Nanopart Res; 2023; 25(3):43. PubMed ID: 36875184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biomedical applications, and toxicity of CuO nanoparticles.
    Naz S; Gul A; Zia M; Javed R
    Appl Microbiol Biotechnol; 2023 Feb; 107(4):1039-1061. PubMed ID: 36635395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview on experimental models of interactions between nanoparticles and the immune system.
    Najafi-Hajivar S; Zakeri-Milani P; Mohammadi H; Niazi M; Soleymani-Goloujeh M; Baradaran B; Valizadeh H
    Biomed Pharmacother; 2016 Oct; 83():1365-1378. PubMed ID: 27580456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavior and Potential Impacts of Metal-Based Engineered Nanoparticles in Aquatic Environments.
    Peng C; Zhang W; Gao H; Li Y; Tong X; Li K; Zhu X; Wang Y; Chen Y
    Nanomaterials (Basel); 2017 Jan; 7(1):. PubMed ID: 28336855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation of nanoparticles in nanomedicine applications.
    Jiao Q; Li L; Mu Q; Zhang Q
    Biomed Res Int; 2014; 2014():426028. PubMed ID: 24949448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional DNA Molecules Enable Selective and Stimuli-Responsive Nanoparticles for Biomedical Applications.
    Li L; Xing H; Zhang J; Lu Y
    Acc Chem Res; 2019 Sep; 52(9):2415-2426. PubMed ID: 31411853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in engineered nanosystems: immunomodulatory interactions for therapeutic applications.
    Khatua R; Bhar B; Dey S; Jaiswal C; J V; Mandal BB
    Nanoscale; 2024 Jul; 16(27):12820-12856. PubMed ID: 38888201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review on Metal-Based Nanoparticles: Role of Reactive Oxygen Species in Renal Toxicity.
    Makhdoumi P; Karimi H; Khazaei M
    Chem Res Toxicol; 2020 Oct; 33(10):2503-2514. PubMed ID: 32909744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotoxicity of zinc oxide nanoparticles with different size and electrostatic charge.
    Kim CS; Nguyen HD; Ignacio RM; Kim JH; Cho HC; Maeng EH; Kim YR; Kim MK; Park BK; Kim SK
    Int J Nanomedicine; 2014; 9 Suppl 2(Suppl 2):195-205. PubMed ID: 25565837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
    Revia RA; Stephen ZR; Zhang M
    Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity Concerns of Therapeutic Nanomaterials.
    Singla R; Sharma C; Shukla AK; Acharya A
    J Nanosci Nanotechnol; 2019 Apr; 19(4):1889-1907. PubMed ID: 30486930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in mice.
    Lee S; Kim MS; Lee D; Kwon TK; Khang D; Yun HS; Kim SH
    Int J Nanomedicine; 2013; 8():147-58. PubMed ID: 23326190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle-induced immune response: Health risk versus treatment opportunity?
    Pondman K; Le Gac S; Kishore U
    Immunobiology; 2023 Mar; 228(2):152317. PubMed ID: 36592542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative safety analysis of bactericidal nano-colloids: Assessment of potential functional toxicity and radical scavenging action.
    Hashmi MU; Khalid N; Alam T; Hanif R; Janjua HA
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110508. PubMed ID: 31546223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity evaluation of engineered nanoparticles for medical applications using pulmonary epithelial cells.
    Guadagnini R; Moreau K; Hussain S; Marano F; Boland S
    Nanotoxicology; 2015 May; 9 Suppl 1():25-32. PubMed ID: 24286383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.